MedTrace Logo

Screening Tests in Detecting Colorectal Cancer

NCT00025025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4482

Last updated 2016-07-04

No results posted yet for this study

Summary

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for colorectal cancer.

PURPOSE: Randomized screening trial to compare the effectiveness of fecal occult blood testing with that of DNA-based testing of stool and blood in identifying colorectal cancer.

Conditions

Interventions

OTHER

sample testing

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mayo Clinic

    collaborator OTHER

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • David A. Ahlquist, MD · Mayo Clinic

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00025025 on ClinicalTrials.gov